Jessie J. Xie
As a senior associate in our Life Science and Healthcare Group, Jessie has developed her practice to cover all types of regulatory work in the medical device, pharmaceutical, healthcare, food and cosmetic industry sectors in China. She believes that the goal is not always to answer the question, but to help you achieve a competitive advantage and minimize regulatory risk. Jessie is familiar with product approval, clinical trials, adverse event report, product recalls, labeling, advertising requirements, as well as compliance with Chinese laws and regulations relating to local manufacturing and global distribution of medical devices, drugs, food and cosmetic.
She has worked with multinational medical device and pharmaceutical companies to spot regulatory risks, prevent problems from happening, and resolve them in a practical manner.She has also worked with foreign universities to develop cooperative research programs in China. She has helped healthcare companies with the establishment of jointly-operated hospitals in China. Jessie also advises extensively on privacy, data protection, encryption, commercial franchising, and direct selling practice – the areas that are rapidly changing and highly regulated in China.
Areas of Focus
Advising a French medical device company on contractual arrangements with its distributors and trading partners, and regulatory requirements for its onshore operating entities.
Advising a global jeweller and luxury goods retailer in relation to personal data protection, transfer and collection.
Advising a leading international company on its coffee brand franchise in China.
Advising a multinational pharmaceutical company in relation to the management and transfer of employee and patients data, develop the internal privacy policies.
Advising a U.S. based international company on its equity investment in a health care group.
Advising a U.S. medical device company on various matters including clinical trial, product recall, device refurbishment, product labels, product registrations, etc.
Advising a U.S. research institution on its collaborative project with Chinese parties on establishment of a cancer tissue repository in China.
Advising a U.S. university on hosting a medical facility on the campus.
Advising various clients on regulations for advertisement and promotion of pharmaceutical and medical devices in China.
Advising various international companies on use and import of foreign encryption products.
Representing a German pharmaceutical company on restructuring its China entity which distributes drug products from an EJV into a CJV, and preparing relevant contracts.
Representing a leading U.S. based hospital group in negotiations to establish a jointly-operated hospital in China.